TREATMENT SATISFACTION AND JOINT HEALTH OUTCOMES WITHIN A REAL-WORLD HAEMOPHILIA B POPULATION: THE ADELPHI DISEASE SPECIFIC PROGRAMMESURVEY
a Hospital Universitario La Paz-IdiPaz; Servicio de Hematología, Autonoma University, Madrid, Spain
b Novo Nordisk, Zürich, Switzerland
c Adelphi Real World, Bollington, United Kingdom
d Center for Bleeding Disorders and Coagulation, Careggi University Hospital, Florence, Italy
e Novo Nordisk Farmacêutica do Brasil Ltda, São Paulo, SP, Brazil
Lido
408
Vezesque se leu este artigo
148
Total PDF
260
Total HTML
| Ano/Mês | Html | Total | |
|---|---|---|---|
| 2025 6 | 24 | 13 | 37 |
| 2025 5 | 36 | 20 | 56 |
| 2025 4 | 33 | 9 | 42 |
| 2025 3 | 44 | 7 | 51 |
| 2025 2 | 41 | 17 | 58 |
| 2025 1 | 18 | 15 | 33 |
| 2024 12 | 16 | 13 | 29 |
| 2024 11 | 31 | 31 | 62 |
| 2024 10 | 17 | 23 | 40 |
